Abhinav Vepa

Dr. Abhinav Vepa

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
AVAbhinav Vepa
Abhinav Vepa
JBJoseph P. Bae
Joseph P. Bae
FAFaheem Ahmed
Faheem Ahmed
MPManish Pareek
Manish Pareek
KKKamlesh Khunti
Kamlesh Khunti

5 May 2022 in Public Health
Verified
Journal Article
Closed access
NSNader Salari
Nader Salari
AVAbhinav Vepa
Abhinav Vepa
ADAlireza Daneshkhah
Alireza Daneshkhah
NDN. Darvishi
N. Darvishi
HGHooman Ghasemi
Hooman Ghasemi
Masoud MohammadiMasoud Mohammadi
Masoud Mohammadi

AVAbhinav Vepa
Abhinav Vepa
ASAmer Saleem
Amer Saleem
KRKambiz Rakhshanbabanari
Kambiz Rakhshanbabanari
ADAlireza Daneshkhah
Alireza Daneshkhah
TSTabassom Sedighi
Tabassom Sedighi
PCPrithwiraj Chakrabarti
Prithwiraj Chakrabarti
Background: Within the UK, COVID-19 has contributed towards over 103,000 deaths. Although multiple risk factors for COVID-19 have been identified, using this data to improve clinical care has proven challenging. The main aim of this study is to develop a reliable, multivariable predictive model for COVID-19 in-patient outcomes, thus enabling risk-stratification and earlier clinical decision-making. Methods: Anonymised data consisting of 44 independent predictor variables from 355 adults diagnosed with COVID-19, at a UK hospital, was manually extracted from electronic patient records for retrospective, case–control analysis. Primary outcomes included inpatient mortality, required ventilatory support, and duration of inpatient treatment. Pulmonary embolism sequala was the only secondary outcome. After balancing data, key variables were feature selected for each outcome using random forests. Predictive models were then learned and constructed using Bayesian networks. Results: The proposed probabilistic models were able to predict, using feature selected risk factors, the probability of the mentioned outcomes. Overall, our findings demonstrate reliable, multivariable, quantitative predictive models for four outcomes, which utilise readily available clinical information for COVID-19 adult inpatients. Further research is required to externally validate our models and demonstrate their utility as risk stratification and clinical decision-making tools.

30 October 2020 in Sensors
Verified
Journal Article
Open access
PDF file
XWXueyang Wang
Xueyang Wang
AQArham Qureshi
Arham Qureshi
AVAbhinav Vepa
Abhinav Vepa
URUsama Rahman
Usama Rahman
APArnab Palit
Arnab Palit
MEMark Elliott
Mark Elliott
There is increasing evidence that pelvic mobility is a critical factor to consider in implant alignment during total hip arthroplasty (THA). Here, we test the feasibility of using an inertial sensor fitted across the sacrum to measure change in pelvic tilt, and hence screen for patients with high pelvic mobility. Patients (n = 32, mean age: 57.4 years) due to receive THA surgery participated in the study. Measures of pelvic tilt were captured simultaneously using the device and radiograph in three functional positions: Standing, flexed-seated, and step-up. We found a strong correlation between the device and radiograph measures for the change in pelvic tilt measure from standing to flexed-seated position (R2 = 0.911); 75% of absolute errors were under 5 degrees. We demonstrated that the device can be used as a screening tool to rapidly identify patients who would benefit from more detailed surgical planning of implant positioning to reduce future risks of impingement and dislocation.

29 December 2022 in Sensors
Verified
Journal Article
Open access
PDF file
SVSushanth Vayalapra
Sushanth Vayalapra
XWXueyang Wang
Xueyang Wang
AQArham Qureshi
Arham Qureshi
AVAbhinav Vepa
Abhinav Vepa
URUsama Rahman
Usama Rahman
MEMark Elliott
Mark Elliott
Consideration of pelvic mobility when positioning implants for total hip arthroplasty (THA) has been shown to reduce the risk of complications such as dislocation, squeaking and excessive wear. We aim to test the repeatability of pelvic tilt measurements taken between three positions (standing, flexed-seated and step-up) by an inertial measurement unit (IMU) and hence, evaluate their reliability in screening for high pelvic mobility in patients undergoing THA. The repeated IMU measurements of pelvic tilt were analysed for consistency and compared with measures taken by x-ray analysis. Our study showed greater variation in measures taken by the IMU particularly in the flexed-seated position. The patient’s pelvic tilt in this position negatively correlated with their mid-back angle, suggesting the posture of the patient is a source of variation in the flexed-seated position if not kept consistent during assessments. IMUs were overall able to produce accurate and reliable measurements of pelvic tilt; however, protocols will need to be adjusted to factor in a patient’s mid-back angle when taking future readings.

20 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
AVAbhinav Vepa
Abhinav Vepa
ASAmer Saleem
Amer Saleem
KRKambiz Rakhshanbabanari
Kambiz Rakhshanbabanari
AOAmr Omar
Amr Omar
DDDiana Dharmaraj
Diana Dharmaraj
ADAlireza Daneshkhah
Alireza Daneshkhah
Introduction: Within the UK, COVID-19 has contributed towards over 103,000 deaths. Multiple risk factors for COVID-19 have been identified including various demographics, co-morbidities, biochemical parameters, and physical assessment findings. However, using this vast data to improve clinical care has proven challenging. Aims: to develop a reliable, multivariable predictive model for COVID-19 in-patient outcomes, to aid risk-stratification and earlier clinical decision-making. Methods: Anonymized data regarding 44 independent predictor variables of 355 adults diagnosed with COVID-19, at a UK hospital, was manually extracted from electronic patient records for retrospective, case-controlled analysis. Primary outcomes included inpatient mortality, level of ventilatory support and oxygen therapy required, and duration of inpatient treatment. Secondary pulmonary embolism was the only secondary outcome. After balancing data, key variables were feature selected for each outcome using random forests. Predictive models were created using Bayesian Networks, and cross-validated. Results: Our multivariable models were able to predict, using feature selected risk factors, the probability of inpatient mortality (F1 score 83.7%, PPV 82%, NPV 67.9%); level of ventilatory support required (F1 score varies from 55.8% “High-flow Oxygen level” to 71.5% “ITU-Admission level”); duration of inpatient treatment (varies from 46.7% for “≥ 2 days but < 3 days ” to 69.8% “≤ 1 day ”); and risk of pulmonary embolism sequelae (F1 score 85.8%, PPV of 83.7%, and NPV of 80.9%). Conclusion: Overall, our findings demonstrate reliable, multivariable predictive models for 4 outcomes, that utilize readily available clinical information for COVID-19 adult inpatients. Further research is required to externally validate our models and demonstrate their utility as clinical decision-making tools. Highlights: Using COVID-19 risk-factor data to assist clinical decision making is a challenge Anonymous data from 355 COVID-19 inpatients was collected & balanced Key independent variables were feature selected for 4 different outcomes Accurate, multi-variable predictive models were computed, using Bayesian Networks Future research should externally validate our models & demonstrate clinical utility